Cencora Raises Earnings Outlook, Expands Buyback Capacity
CONSHOHOCKEN, PA — Cencora (NYSE: COR) raised its fiscal 2026 earnings outlook and authorized an additional $2 billion share repurchase program, signaling confidence in cash generation as the pharmaceutical distribution …
Cencora Raises Earnings Outlook, Expands Buyback Capacity Read More